World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
73
Citations
19183
World Ranking
5932
National Ranking
2807

Martin Hoenigl publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Martin Hoenigl sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 345 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Martin Hoenigl D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Martin Hoenigl sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

Martin Hoenigl is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medicine, with specific expertise in infectious diseases. They have contributed extensively to the study of fungal infections and antifungal resistance.

The scientist's publication record includes work on a variety of topics related to fungal infections, mycology, and respiratory diseases. Key topics in their research include:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Plant pathogens and fungal diseases
  • Infectious diseases and mycology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Interstitial lung diseases and idiopathic pulmonary fibrosis
  • HIV/AIDS research and interventions

Recent papers authored or co-authored by Martin Hoenigl cover issues related to COVID-19-associated fungal infections and antifungal treatments. Notable papers include:

  • "Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance," 2020, The Lancet Infectious Diseases
  • "COVID-19-associated fungal infections," 2022, Nature Microbiology
  • "COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment," 2020, Journal of Fungi
  • "The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin," 2021, Drugs
  • "Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology," 2021, The Lancet Infectious Diseases

Martin Hoenigl frequently publishes in several scientific journals, reflecting a broad engagement with mycology and infectious disease research. The main publication venues include:

  • Open Forum Infectious Diseases
  • Journal of Fungi
  • Mycoses
  • Mycopathologia
  • Clinical Microbiology and Infection

The scientist has collaborated with several recurrent coauthors, indicating ongoing research partnerships. Frequent collaborators include Oliver A. Cornely, Jon Salmanton-García, Jean-Pierre Gangneux, Juergen Prattes, and Philipp Koehler.

In addition to journal articles, Martin Hoenigl has contributed to book publications, including a work published by Springer International Publishing titled Infection Management in Hematology (2020).

Among their professional recognitions, Martin Hoenigl is a Fellow of the European Confederation of Medical Mycology (ECMM), underscoring their involvement in this specialized field.

Best Publications

  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    Oliver A. Cornely;Ana Alastruey-Izquierdo;Dorothee Arenz;Sharon C. A. Chen

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

    Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  • The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.

    Martin Hoenigl;Martin Hoenigl;Rosanne Sprute;Matthias Egger;Amir Arastehfar

  • COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment

    Amir Arastehfar;Agostinho Carvalho;Frank L. van de Veerdonk;Jeffrey D. Jenks

  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

    Martin Hoenigl;Jon Salmanton-García;Thomas J. Walsh;Thomas J. Walsh;Marcio Nucci

  • COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

    Livio Pagano;Livio Pagano;Jon Salmanton-García;Francesco Marchesi;Alessandro Busca

  • Performance of Galactomannan, Beta-d-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis

    M. Hoenigl;J. Prattes;B. Spiess;J. Wagner

  • Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.

    Amir Arastehfar;Toni Gabaldón;Toni Gabaldón;Rocio Garcia-Rubio;Jeffrey D Jenks

  • COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?

    Amir Arastehfar;Agostinho Carvalho;M. Hong Nguyen;Mohammad Taghi Hedayati

  • Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.

    Juergen Prattes;Joost Wauters;Daniele Roberto Giacobbe;Jon Salmanton-García

  • Improvement in the outcome of invasive fusariosis in the last decade

    M. Nucci;K. A. Marr;M. J G T Vehreschild;C. A. de Souza

  • Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia

    Helmut J F Salzer;Guido Schäfer;Martin Hoenigl;Martin Hoenigl;Gunar Günther

  • Diagnosing COVID-19-associated pulmonary aspergillosis.

    Paul E. Verweij;Jean Pierre Gangneux;Matteo Bassetti;Roger J.M. Brüggemann

  • Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men.

    Martin Hoenigl;Antoine Chaillon;David J. Moore;Sheldon R. Morris

  • Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.

    Oliver A. Cornely;Martin Hoenigl;Martin Hoenigl;Cornelia Lass‐Flörl;Sharon C. ‐A. Chen

  • Contaminated Handwashing Sinks as the Source of a Clonal Outbreak of KPC-2-Producing Klebsiella oxytoca on a Hematology Ward

    Eva Leitner;Gernot Zarfel;Josefa Luxner;Kathrin Herzog

  • Novel Tests for Diagnosis of Invasive Aspergillosis in Patients with Underlying Respiratory Diseases

    Juergen Prattes;Holger Flick;Florian Prüller;Christoph Koidl

  • Breakthrough invasive fungal infections: Who is at risk?

    Jeffrey D. Jenks;Oliver A. Cornely;Sharon C.A. Chen;George R. Thompson

  • Treatment of Aspergillosis.

    Jeffrey D Jenks;Martin Hoenigl

  • Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings

    David W Denning;Iain D Page;Jeremiah Chakaya;Kauser Jabeen

Frequent Co-Authors

Robert Krause
Robert Krause Medical University of Graz
Oliver A. Cornely
Oliver A. Cornely University of Cologne
Susan J. Little
Susan J. Little University of California, San Diego
Philipp Koehler
Philipp Koehler Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
Davey M. Smith
Davey M. Smith University of California, San Diego
Sara Gianella
Sara Gianella University of California, San Diego
Sharon C.-A. Chen
Sharon C.-A. Chen Westmead Hospital
Ana Alastruey-Izquierdo
Ana Alastruey-Izquierdo Instituto de Salud Carlos III
Livio Pagano
Livio Pagano Catholic University of the Sacred Heart

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Biology and Biochemistry in the USA opens doors to diverse career pathways, especially in health information and medical coding fields. Students interested in the intersection of science and healthcare technology often consider a health information management degree. These online programs are highly affordable and lead to in-demand roles managing patient data and health informatics.

A popular career choice is becoming a certified professional coder, which allows you to work with medical billing and coding for hospitals and clinics. The distinctions between various coding certifications like CPC and CCS can impact your role, salary, and day-to-day tasks. If you’re curious about earnings, learn more about medical coding salary prospects, which continue to grow with the healthcare industry's expansion.

Medical coding offers strong job security, remote work options, and clear pathways for advancement. However, it’s important to weigh all sides; check out the medical coding job outlook to understand both the benefits and challenges of this rewarding career path.

Best Scientists Citing Martin Hoenigl

Trending Scientists

Recently Published Articles